Skip to content

A RANDOMISED CONTROLLED CLINICAL TRIAL TO STUDY THE YONIGADHEEKARANA EFFICACY OF LODHRA-KATUTUMBI TAILA YONIPICHUDHARANA AND COMPARE THE EFFICACY OF THIS DRUG WITH PALASHADI TAILA YONIPICHUDHARANA IN YONIBHRAMSHA (PELVIC ORGAN PROLAPSE)

Yonigadheekarana efficacy of Lodhra-Katutumbi Taila and Palashadi Taila – Yonipichudharana in Yonibhramsha (Pelvic Organ Prolapse) : A Randomised Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072620
Enrollment
40
Registered
2024-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N819- Female genital prolapse, unspecified

Interventions

None listed

Sponsors

DR APOORVA ASHOK SHETTY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with Yonibhramsha by POP-Q Scale 2.Subjects fulfilling diagnostic criteria 3.Married women of age group : 30-70 years 4.Parous women

Exclusion criteria

Exclusion criteria: 1.Known case of genital, bladder and rectal organ malignancies 2.Any trauma leading to POP 3.Infectious disorders of genital tract 4.Congenital anomalies leading to POP 5.Pregnant woman 6.Prolapse with fibroid uterus, ovarian or vaginal cyst 7.Infectious diseases like HIV, VDRL, HBsAg 8.Any systemic illness like hypertension, diabetes, tuberculosis and chronic cough 9.Subjects with chronic constipation 10.Parity = 4 11.Procidentia 12.Subjects with irregular menstrual bleeding

Design outcomes

Primary

MeasureTime frame
The effect of treatment will be assessed on the basis of subjective parameters 1.Feeling of mass per vaginum 2.Low back ache 3.Frequency of micturition 4.Stress Urinary Incontinence 5.Difficulty in emptying bladder 6.Straining during defecationTimepoint: On 21st day following treatment in 2nd month

Secondary

MeasureTime frame
The effect of treatment will be assessed on the basis of objective parameters 1.Staging degree of prolapse by POP-Q Scale 2.Evaluation of strength of pelvic floor muscles by Modified Oxford Grading System 3.Pelvic floor muscle assessment by PERFECT SchemeTimepoint: On 1st, 7th & 14th day of treatment for 2 consecutive months & 21st day following treatment

Countries

India

Contacts

Public ContactDR APOORVA ASHOK SHETTY

ALVAS AYURVEDA MEDICAL COLLEGE, MOODUBIDIRE

drasokan24@gmail.com6361740431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026